Apolipoprotein E4: A Risk Factor for Successful Cognitive Aging

Apolipoprotein E is a plasma protein that has an important role in transport and metabolism of lipids in serum as well as central nervous system. Among the 3 common alleles, the ε2 allele has the most stable structure followed by ε3 and ε4 in order. There is evidence for a deleterious role of ε4 allele by atherosclerosis and amyloid beta accumulation in brain and body. The presence and gene dose of ε4 allele are risk factors for late-onset Alzheimer's disease. Apolipoprotein E ε4 may have a role in the pathology of amyloid beta and tau and it has a strong relationship with the early onset of late-onset Alzheimer's disease. However, early-onset Alzheimer's disease has a weaker relationship with ε4 allele of apolipoprotein E.

[1]  John Seibyl,et al.  Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study , 2015, Alzheimer's & Dementia.

[2]  R. Quirion,et al.  Regional and sub-regional differences in hippocampal GABAergic neuronal vulnerability in the TgCRND8 mouse model of Alzheimer's disease , 2015, Front. Aging Neurosci..

[3]  I. Dewachter,et al.  Models of β-amyloid induced Tau-pathology: the long and “folded” road to understand the mechanism , 2014, Molecular Neurodegeneration.

[4]  Jaekwang Kim,et al.  Apolipoprotein E in Synaptic Plasticity and Alzheimer’s Disease: Potential Cellular and Molecular Mechanisms , 2014, Molecules and cells.

[5]  J. Herz,et al.  More than Cholesterol Transporters: Lipoprotein Receptors in CNS Function and Neurodegeneration , 2014, Neuron.

[6]  Dong Hee Kim,et al.  Genetic markers for diagnosis and pathogenesis of Alzheimer's disease. , 2014, Gene.

[7]  D. Gaudet,et al.  The potential applications of Apolipoprotein E in personalized medicine , 2014, Front. Aging Neurosci..

[8]  G. Alexander,et al.  Exercise, APOE genotype, and the evolution of the human lifespan , 2014, Trends in Neurosciences.

[9]  O. Andreassen,et al.  The role of clusterin in amyloid-β-associated neurodegeneration. , 2014, JAMA neurology.

[10]  Mark T. W. Ebbert,et al.  Genetics of Alzheimer's Disease , 2013, BioMed research international.

[11]  H. Rhinn,et al.  Integrative genomics identifies APOE ε4 effectors in Alzheimer's disease , 2013, Nature.

[12]  T. Rohn.  Proteolytic Cleavage of Apolipoprotein E4 as the Keystone for the Heightened Risk Associated with Alzheimer’s Disease , 2013, International journal of molecular sciences.

[13]  R. Goutagny,et al.  Hippocampal oscillatory activity in Alzheimer's disease: toward the identification of early biomarkers? , 2013, Aging and disease.

[14]  R. Mahley,et al.  Apolipoprotein E Sets the Stage: Response to Injury Triggers Neuropathology , 2012, Neuron.

[15]  D. Watts,et al.  The Apolipoprotein E (APOE) Gene Appears Functionally Monomorphic in Chimpanzees (Pan troglodytes) , 2012, PloS one.

[16]  R. Tanzi.  The genetics of Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.

[17]  Jeffrey W. Habig,et al.  Identification of an amino-terminal fragment of apolipoprotein E4 that localizes to neurofibrillary tangles of the Alzheimer's disease brain , 2012, Brain Research.

[18]  M. Copetti,et al.  Neuropsychiatric symptoms and functional status in Alzheimer's disease and vascular dementia patients. , 2012, Current Alzheimer research.

[19]  S. Weggen,et al.  Molecular consequences of amyloid precursor protein and presenilin mutations causing autosomal-dominant Alzheimer's disease , 2012, Alzheimer's Research & Therapy.

[20]  D. Holtzman,et al.  CSF biomarkers for Alzheimer's disease: current utility and potential future use , 2011, Neurobiology of Aging.

[21]  A. Fagan,et al.  Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance , 2011, Science Translational Medicine.

[22]  Hong-Liang Zhang,et al.  Cross-Talk between Apolipoprotein E and Cytokines , 2011, Mediators of inflammation.

[23]  W. Chan,et al.  Apolipoprotein E Polymorphism and Age at Onset of Alzheimer’s Disease in a Quadriethnic Sample , 2011, Dementia and Geriatric Cognitive Disorders.

[24]  R. Bateman,et al.  Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease , 2010, Science.

[25]  C. Kuzawa,et al.  Worldwide allele frequencies of the human apolipoprotein E gene: climate, local adaptations, and evolutionary history. , 2010, American journal of physical anthropology.

[26]  C. Ki,et al.  Discrepancy in genotyping of apolipoprotein E between allele-specific PCR and fluorescence resonance energy transfer or sequencing. , 2010, The Korean journal of laboratory medicine.

[27]  Todd E. Golde,et al.  Targeting Aβ and tau in Alzheimer's disease, an early interim report , 2010, Experimental Neurology.

[28]  R. Elston,et al.  A comparative study to screen dementia and APOE genotypes in an ageing East African population , 2010, Neurobiology of Aging.

[29]  D. Michaelson,et al.  Possible Role of Tau in Mediating Pathological Effects of apoE4 in vivo prior to and following Activation of the Amyloid Cascade , 2010, Neurodegenerative Diseases.

[30]  Michael Weiner,et al.  Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease , 2009, Annals of neurology.

[31]  R. Mahley,et al.  Alzheimer disease: Multiple causes, multiple effects of apolipoprotein E4, and multiple therapeutic approaches , 2009, Annals of neurology.

[32]  Massimo Filippi,et al.  Apolipoprotein E ε4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia , 2009, Proceedings of the National Academy of Sciences.

[33]  Rossana Ganzola,et al.  Mapping local hippocampal changes in Alzheimer's disease and normal ageing with MRI at 3 Tesla. , 2008, Brain : a journal of neurology.

[34]  L. Mucke,et al.  Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model , 2007, Science.

[35]  Michael P. Coleman,et al.  Neuronal death: where does the end begin? , 2007, Trends in Neurosciences.

[36]  G. Moretto,et al.  Structural and phylogenetic approaches to assess the significance of human Apolipoprotein E variation. , 2006, Molecular genetics and metabolism.

[37]  K. Weisgraber,et al.  Apolipoprotein E structure: insights into function. , 2006, Trends in biochemical sciences.

[38]  K. Hall,et al.  International Studies in Dementia With Particular Emphasis on Populations of African Origin , 2006, Alzheimer disease and associated disorders.

[39]  David Walker,et al.  Profile and Regulation of Apolipoprotein E (ApoE) Expression in the CNS in Mice with Targeting of Green Fluorescent Protein Gene to the ApoE Locus , 2006, The Journal of Neuroscience.

[40]  R. Mahley,et al.  Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Irwin D Kuntz,et al.  Apolipoprotein (apo) E4 enhances amyloid beta peptide production in cultured neuronal cells: apoE structure as a potential therapeutic target. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[42]  J. Hardy,et al.  Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice , 2005, Neuron.

[43]  Holly Soares,et al.  Cerebrospinal fluid β-amyloid1–42 and tau in control subjects at risk for Alzheimer’s disease: The effect of APOE ε4 allele , 2004, Biological Psychiatry.

[44]  R. Mahley,et al.  Increased tau Phosphorylation in Apolipoprotein E4 Transgenic Mice Is Associated with Activation of Extracellular Signal-regulated Kinase , 2004, Journal of Biological Chemistry.

[45]  Dominic M. Walsh,et al.  Deciphering the Molecular Basis of Memory Failure in Alzheimer's Disease , 2004, Neuron.

[46]  C. Finch,et al.  Meat‐Adaptive Genes and the Evolution of Slower Aging in Humans , 2004, The Quarterly Review of Biology.

[47]  Henry Rusinek,et al.  Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging. , 2003, Radiology.

[48]  G. Gambina,et al.  Screening of two mutations at exon 3 of the apolipoprotein E gene (sites 28 and 42) in a sample of patients with sporadic late-onset Alzheimer’s disease , 2003, Neurobiology of Aging.

[49]  D. Bennett,et al.  Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status. , 2003, Archives of neurology.

[50]  Hiroaki Kazui,et al.  Accelerated hippocampal atrophy in Alzheimer's disease with apolipoprotein E ε4 allele , 2002 .

[51]  D. Selkoe.  Clearing the Brain's Amyloid Cobwebs , 2001, Neuron.

[52]  Q. Qu,et al.  [An association analysis of apolipoprotein E genotypes with Alzheimer's disease in Chinese population]. , 2001, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae.

[53]  Robert V Farese,et al.  Introduction of human apolipoprotein E4 “domain interaction” into mouse apolipoprotein E , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[54]  D. Selkoe.  Alzheimer's disease: genes, proteins, and therapy. , 2001, Physiological reviews.

[55]  E. Boerwinkle,et al.  Sequence diversity and large-scale typing of SNPs in the human apolipoprotein E gene. , 2000, Genome research.

[56]  E. Boerwinkle,et al.  Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism. , 2000, American journal of human genetics.

[57]  S. Younkin,et al.  Biochemical detection of Aβ isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer’s disease , 2000 .

[58]  B T Hyman,et al.  Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. , 2000, The American journal of pathology.

[59]  I. Tesseur,et al.  Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice. , 2000, The American journal of pathology.

[60]  R. Mahley,et al.  Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond. , 1999, Current opinion in lipidology.

[61]  K. Marder,et al.  The APOE- (cid:101) 4 Allele and the Risk of Alzheimer Disease Among African Americans, Whites, and Hispanics , 2001 .

[62]  J. Haines,et al.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.

[63]  J. Haines,et al.  Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .

[64]  R. Nixon,et al.  Increased Neuronal Endocytosis and Protease Delivery to Early Endosomes in Sporadic Alzheimer’s Disease: Neuropathologic Evidence for a Mechanism of Increased β-Amyloidogenesis , 1997, The Journal of Neuroscience.

[65]  M. Pericak-Vance,et al.  Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[66]  A. M. Saunders,et al.  Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease , 1994, Nature Genetics.

[67]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[68]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[69]  John Q. Trojanowski,et al.  The disordered neuronal cytoskeleton in Alzheimer's disease , 1992, Current Biology.

[70]  J. Taylor,et al.  Glycosylation of human apolipoprotein E. The carbohydrate attachment site is threonine 194. , 1989, The Journal of biological chemistry.

[71]  I. Knuesel,et al.  Deciphering the mechanism underlying late-onset Alzheimer disease , 2013, Nature Reviews Neurology.

[72]  J. Poirier,et al.  2 International Journal of Alzheimer ’ s Disease 2 . Structural Organization and Toxicological Properties of the APOE Protein 2 , 2011 .

[73]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[74]  I. Shin,et al.  Association of Apolipoprotein E Gene Polymorphism With Cognitive Function of the Elderly Residents in a Rural Community , 2009 .

[75]  Holly Soares,et al.  Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele. , 2004, Biological psychiatry.

[76]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[77]  M. Kindy,et al.  Apolipoprotein E and Alzheimer's disease: the protective effects of ApoE2 and E3. , 2002, Journal of Alzheimer's disease : JAD.

[78]  Hiroaki Kazui,et al.  Accelerated hippocampal atrophy in Alzheimer's disease with apolipoprotein E epsilon4 allele. , 2002, Annals of neurology.

[79]  S. Younkin,et al.  Biochemical detection of Abeta isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease. , 2000, Biochimica et biophysica acta.

[80]  K. Weisgraber.  Apolipoprotein E: structure-function relationships. , 1994, Advances in protein chemistry.

[81]  A. Hofman,et al.  Apolipoprotein E4 allele in a population–based study of early–onset Alzheimer's disease , 1994, Nature Genetics.